Literature DB >> 7471213

The ovalbumin gene family: hormonal control of X and Y gene transcription and mRNA accumulation.

M LeMeur, N Glanville, J L Mandel, P Gerlinger, R Palmiter, P Chambon.   

Abstract

The ovalbumin gene family is composed of three genes, X, Y and ovalbumin, which are expressed in laying hen oviduct. We have analyzed the in vivo transcription products of X and Y genes and the effect of steroid hormones on their synthesis and accumulation. As in the case of ovalbumin, the complete gene transcripts and processing intermediates are present in the poly(A)+ RNA fraction. The mature RNAs are found in polysomes and are translated into proteins. The expression of X and Y genes is controlled by steroid hormones: X and Y RNAs are not detectable in oviducts from chicks withdrawn from estrogen stimulation, whereas in chicks stimulated with estrogen for 7 days, X RNA represents 0.3% and Y RNA 0.8% of ovalbumin mRNA. In laying hen, however, the levels of X and Y RNAs are about 2% of ovalbumin mRNA. After stimulation with other steroid hormones, alone or in combination, the level of X and Y RNA does not achieve that detected in laying hen. Progesterone has a much weaker effect on X RNA accumulation than on that of Y and ovalbumin mRNAs. Studies with isolated nuclei show that X and Y gene expression is regulated by hormones at the level of transcription. However, the differences observed between the transcription rates and the accumulation of X and Y mRNAs suggest that the expression of X and Y genes could also be controlled at the levels of RNA processing and/or mRNA stability.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7471213     DOI: 10.1016/0092-8674(81)90152-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  62 in total

1.  One hundred years of hormones.

Authors:  Jamshed R Tata
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

2.  Isolation and characterization of the prune locus of Drosophila melanogaster.

Authors:  D H Teng; L B Bender; C M Engele; S Tsubota; T Venkatesh
Journal:  Genetics       Date:  1991-06       Impact factor: 4.562

3.  The Drosophila melanogaster actin 5C gene uses two transcription initiation sites and three polyadenylation sites to express multiple mRNA species.

Authors:  B J Bond; N Davidson
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  In vivo splicing of the premRNAs from early region 3 of adenovirus-2: the products of cleavage at the 5' splice site of the common intron.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

5.  Genes in the GABA Pathway Increase in the Lateral Thalamus of Sprague-Dawley Rats During the Proestrus/Estrus Phase.

Authors:  Mikhail Umorin; Crystal Stinson; Larry L Bellinger; Phillip R Kramer
Journal:  J Cell Physiol       Date:  2015-09-30       Impact factor: 6.384

6.  A DNA sequence of Drosophila melanogaster with a differential telomeric distribution.

Authors:  R Renkawitz-Pohl; S Bialojan
Journal:  Chromosoma       Date:  1984       Impact factor: 4.316

7.  Tissue distribution of angiotensinogen mRNA during experimental inflammation.

Authors:  C Klett; W Hellmann; D Ganten; E Hackenthal
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

8.  Expression of glutathione S-transferase during rat liver development.

Authors:  L B Tee; K S Gilmore; D J Meyer; B Ketterer; Y Vandenberghe; G C Yeoh
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

Review 9.  Aspects of molecular biology and biochemistry of the cardiac renin-angiotensin system.

Authors:  K Lindpaintner; M Jin; M Wilhelm; M Toth; D Ganten
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

10.  Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors.

Authors:  E Hummler; T J Cole; J A Blendy; R Ganss; A Aguzzi; W Schmid; F Beermann; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.